RSVAX
Price
$26.05
Change
+$0.21 (+0.81%)
Updated
Dec 3 closing price
Net Assets
255.38M
VEVYX
Price
$46.94
Change
+$0.45 (+0.97%)
Updated
Dec 3 closing price
Net Assets
16B
Interact to see
Advertisement

RSVAX vs VEVYX

Header iconRSVAX vs VEVYX Comparison
Open Charts RSVAX vs VEVYXBanner chart's image
Victory RS Value A
Price$26.05
Change+$0.21 (+0.81%)
VolumeN/A
Net Assets255.38M
Victory Sycamore Established Value Y
Price$46.94
Change+$0.45 (+0.97%)
VolumeN/A
Net Assets16B
RSVAX vs VEVYX Comparison Chart in %
View a ticker or compare two or three
VS
RSVAX vs. VEVYX commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RSVAX is a Buy and VEVYX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VEVYX has more cash in the bank: 16B vs. RSVAX (255M). VEVYX pays higher dividends than RSVAX: VEVYX (1.02) vs RSVAX (0.36). RSVAX was incepted earlier than VEVYX: RSVAX (32 years) vs VEVYX (13 years). RSVAX (1.33) is less costly to investors than VEVYX (0.66). RSVAX is a more actively managed with annual turnover of: 39.00 vs. VEVYX (34.00). RSVAX has a lower initial minimum investment than VEVYX: RSVAX (2500) vs VEVYX (1000000). RSVAX annual gain was more profitable for investors over the last year : -9.99 vs. VEVYX (-12.93). VEVYX return over 5 years is better than : 20.07 vs. RSVAX (14.68).
RSVAXVEVYXRSVAX / VEVYX
Total Expense Ratio1.300.66197%
Annual Report Gross Expense Ratio1.330.66202%
Fund Existence32 years13 years-
Gain YTD4.2942.309186%
Front Load6%N/A-
Min. Initial Investment250010000000%
Min. Initial Investment IRAN/AN/A-
Net Assets255M16B2%
Annual Yield % from dividends0.361.0235%
Returns for 1 year-9.99-12.9377%
Returns for 3 years-0.21-2.229%
Returns for 5 years14.6820.0773%
Returns for 10 years-15.1547.79-32%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PEOPX67.21N/A
N/A
BNY Mellon S&P 500 Index
CENTX14.36N/A
N/A
Centerstone Investors I
JERNX12.34N/A
N/A
Janus Henderson Global Real Estate N
IGIIX43.55N/A
N/A
Nomura Global Growth Fund Class I
RRMVX32.34N/A
N/A
T. Rowe Price Mid-Cap Value R